Clinical Trial Update: Meningococcal B Vaccine in Patients with Asplenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a Meningococcal B vaccine in patients with asplenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asplenia

Drugs mentioned

• Meningococcal B vaccine (Meningococcal B vaccine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Splenectomy; Status | Phase 2 | Status: RECRUITING